{
    "id": "dbpedia_8383_3",
    "rank": 52,
    "data": {
        "url": "https://www.cambridge.org/core/journals/psychological-medicine/article/serotonergic-dysfunction-and-aggression-control1/781161ACDAE2F0267244324D7D47818A",
        "read_more_link": "",
        "language": "en",
        "title": "Serotonergic dysfunction and aggression control1",
        "top_image": "https://static.cambridge.org/covers/PSM_0_0_0/psychological_medicine.jpg?send-full-size-image=true",
        "meta_img": "https://static.cambridge.org/covers/PSM_0_0_0/psychological_medicine.jpg?send-full-size-image=true",
        "images": [
            "https://www.cambridge.org/core/cambridge-core/public/images/icn_circle__btn_close_white.svg",
            "https://www.cambridge.org/core/cambridge-core/public/images/logo_core.png",
            "https://www.cambridge.org/core/cambridge-core/public/images/logo_core.svg",
            "https://www.cambridge.org/core/cambridge-core/public/images/logo_core.svg",
            "https://www.cambridge.org/core/cambridge-core/public/images/logo_core.svg",
            "https://static.cambridge.org/covers/PSM_0_0_0/psychological-medicine.jpg",
            "https://www.cambridge.org/core/page-component/img/save-pdf-icon.080470e.svg",
            "https://www.cambridge.org/core/page-component/img/pdf-download-icon.c7fb40c.svg",
            "https://www.cambridge.org/core/page-component/img/pdf-download-icon.c7fb40c.svg",
            "https://www.cambridge.org/core/page-component/img/dropbox-icon.3d57046.svg",
            "https://www.cambridge.org/core/page-component/img/google-drive-icon.a50193b.svg",
            "https://www.cambridge.org/core/page-component/img/close-icon.194b28a.svg",
            "https://www.cambridge.org/core/page-component/img/share-icon.cbcfad8.svg",
            "https://www.cambridge.org/core/page-component/img/close-icon.194b28a.svg",
            "https://www.cambridge.org/core/page-component/img/cite-icon.44eaaa4.svg",
            "https://www.cambridge.org/core/page-component/img/rights-icon.d4a677c.svg",
            "https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0033291700014604/resource/name/firstPage-S0033291700014604a.jpg",
            "https://assets.crossref.org/logo/crossref-logo-100.png",
            "https://upload.wikimedia.org/wikipedia/commons/a/a9/Google_Scholar_logo_2015.PNG",
            "https://assets.crossref.org/logo/crossref-logo-100.png",
            "https://www.cambridge.org/core/cambridge-core/public/images/cambridge_logo.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Herman M. Van Praag"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "Serotonergic dysfunction and aggression control1 - Volume 21 Issue 1",
        "meta_lang": "en",
        "meta_favicon": "/core/cambridge-core/public/images/favicon.ico",
        "meta_site_name": "Cambridge Core",
        "canonical_link": "https://www.cambridge.org/core/journals/psychological-medicine/article/serotonergic-dysfunction-and-aggression-control1/781161ACDAE2F0267244324D7D47818A",
        "text": "Abstract\n\nAn abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.\n\nType\n\nEditorial\n\nCopyright\n\nCopyright © Cambridge University Press 1991\n\nReferences\n\nApter, A., van Praag, H. M., Plutchik, R., Sevy, S., Korn, M. & Brown, S.-L. (1990). Interrelationship between anxiety, aggression, impulsivity and mood. A possible serotonergically-linked cluster. Psychiatry Research (in the press).Google Scholar\n\nArora, R. C. & Meltzer, H. Y. (1989). Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. American Journal of Psychiatry 146, 730–776.Google ScholarPubMed\n\nAsberg, M., Traskman, L. & Thoren, P. (1976). 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Archives of General Psychiatry 33, 1193–1197.CrossRefGoogle ScholarPubMed\n\nAsberg, M., Bertilsson, L., Matensson, B., Scalia-Tombia, G.-P., Thoren, P. & Traskman, L. (1984). CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica 69, 201–210.CrossRefGoogle ScholarPubMed\n\nCharney, D. S., Wood, S. W. & Henninger, J. R. (1987). Serotonin functions in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and health subjects. Psychopharmacology 92, 14–24.CrossRefGoogle Scholar\n\nCoccaro, E. F., Siever, L. J., Klar, H. M., Maurer, G., Cochrane, K., Cooper, T. B., Mohs, R. C. & Davis, K. L. (1989). Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry 46, 587–599.CrossRefGoogle ScholarPubMed\n\nFishbein, D. H., Lozovsky, D. & Jaffe, J. H. (1989). Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation, in substance abusers. Biological Psychiatry 25, 1049–1066.CrossRefGoogle ScholarPubMed\n\nInvernizzi, R., Berettera, C., Garattini, S. & Samanin, R. (1986). D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. European Journal of Pharmacology 120, 9–15.CrossRefGoogle ScholarPubMed\n\nKahn, R., Wetzler, S., van Praag, H. M. & Asnis, G. M. (1988 a). Behavioral indications of serotonin receptor hypersensitivity in panic disorder. Psychiatry Research 25, 101–104.CrossRefGoogle ScholarPubMed\n\nKahn, R., Wetzler, S., van Praag, H. M. & Asnis, G. M. (1988 b). Neuroendocrine evidence for 5-HT receptor hypersensivity in patients with panic disorder. Psychopharmacology 96, 360–364.CrossRefGoogle Scholar\n\nKorn, M., Brown, S.-L. & van Praag, H. M. (1989). Serotonergic disturbances in suicide.Paper read at the World Congress of Psychiatry,Athens (in the press).Google Scholar\n\nKorn, M. L., Kotler, M., Molcho, A., Grosz, D., Brown, S.-L., Chen, C. & van Praag, H. M. (1990). Suicide and aggression associated with panic attacks. Biological Psychiatry (submitted).Google Scholar\n\nLinnoila, M., Virkhunen, M., Scheinin, M., Nuutila, A., Rimon, R. & Goodwin, F. K. (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sciences 33, 2609–2614.CrossRefGoogle Scholar\n\nMann, J. J., Stanley, M., McBride, A. & McEwen, B. S. (1986). Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry 43, 954–959.CrossRefGoogle ScholarPubMed\n\nMeltzer, H. Y., Perline, R., Tricoy, B. J., Lowy, M. T. & Robertson, A. (1984). Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relations to suicide, psychosis, and depressive symptoms. Archives of General Psychiatry 41, 379–387.CrossRefGoogle ScholarPubMed\n\nMorand, C., Young, J. N. & Ervin, F. R. (1983). Clinical response of aggressive schizophrenics to oral tryptophan. Biological Psychiatry 18, 575–578.Google ScholarPubMed\n\nNinan, P. T., van Kammen, D. P., Scheinin, M., Linnoila, M., Bunney, W. E., & Goodwin, F. K. (1984). CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. American Journal of Psychiatry 141, 566–569.Google ScholarPubMed\n\nOlivier, B., van Dalen, D. & Hartog, J. (1986). A new class of psychotropic drugs: Serenics. Drugs of the Future 11, 473–494.Google Scholar\n\nPlutchik, R., van Praag, H. M. & Conte, H. R. (1989 a). Correlates of suicide and violence risk. III. A two-stage model of countervailing forces. Psychiatry Research 28, 215–225.CrossRefGoogle Scholar\n\nPlulchik, R., van Praag, H. M., Picard, S., Conte, H. R. & Korn, M. (1989 b). Is there a relaton between seriousness of suicide intent and the lethality of the suicide attempt? Psychiatry Research 27, 71–79.CrossRefGoogle Scholar\n\nRoy, A., & Linnoila, M. (1988). Suicidal behavior, impulsiveness and serotonin. Acta Psychiatrica Scandinavica 78, 529–535.CrossRefGoogle ScholarPubMed\n\nRoy, A., Adinoff, B. & Linnoila, M. (1988). Acting out hostility in normal volunteers: negative correlation with levels of 5-HIAA in cerebral spinal fluid. Psychiatry Research 24, 187–194.CrossRefGoogle Scholar\n\nRoy, A., Adinoff, B., Roehirch, L., Lamparski, D., Custer, R., Lorenz, V., Barbaccia, M., Guidotti, A., Costa, E. & Linnoila, M. (1988). Pathological gambling. Archives of General Psychiatry 45, 369–373.CrossRefGoogle ScholarPubMed\n\nRoy, A., Dejong, J. & Linnoila, M. (1989). Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. Archives of General Psychiatry 46, 609–612.CrossRefGoogle ScholarPubMed\n\nSoubrie, P. (1986). Reconciling the role of central serotonin neurons in human and nimal behavior. Behavioral and Nrain Sciences 9, 319–363.CrossRefGoogle Scholar\n\nTraskman, L., Asberg, M., Bertilsson, L. & Sjostrand, L. (1981). Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry 38, 631–636.CrossRefGoogle ScholarPubMed\n\nvan Praag, H. M. (1982). Depression, suicide and the metabolism of serotonin in the brain. Journal of Affective Disorders 4, 275–290.CrossRefGoogle Scholar\n\nvan Praag, H. M. (1983). CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet i, 977–978.CrossRefGoogle Scholar\n\nvan Praag, H. M. (1986 a). (Auto)aggression and CSF 5-HIAA in depression and schizophrenia. Psychopharmacology Bulletin 22, 669–673.Google ScholarPubMed\n\nvan Praag, H. M. (1986 b). Biological suicide research: outcome and limitations. Biological Psychiatry 21, 1305–1323.CrossRefGoogle ScholarPubMed\n\nvan Praag, H. M. (1988). Serotonergic mechanisms and suicidal behaviour. Psychiatry and Psychobiology 3, 335–346.CrossRefGoogle Scholar\n\nvan Praag, H. M. & Korf, J. (1971). Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: a biochemical classification? Psychopharmacologia 19, 148–152.CrossRefGoogle Scholar\n\nvan Praag, H. M. & Plutchik, R. (1985). An empirical study on the ‘cathartic effect’ of attempted suicide. Psychiatry Research 16, 123–130.CrossRefGoogle Scholar\n\nvan Praag, H. M.Ulemann, A. M. & Spitz, J. C. (1965). The vital syndrome interview. A stuctured standard interview for the recognition and registration of the vital depression symptom complex. Psychiatrica Neurologia Neurochirurgia 68, 329–346.Google Scholar\n\nvan Praag, H. M., Korf, J. & Puite, J. (1970). 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225, 1259–1260.CrossRefGoogle ScholarPubMed\n\nVirkkunen, M., Nuttila, A., Goodwin, F. K. & Linnoila, M. (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry 44, 241–247.CrossRefGoogle ScholarPubMed\n\nVirkkunen, M., DeJong, J., Bartko, J. & Linnoila, M. (1989). Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Archives of General Psychiatry 46, 604–606.CrossRefGoogle ScholarPubMed\n\nVolavka, J., Crowner, M., Brizer, D., Convit, A., van Praag, H. M. & Cooper, T. (1990). Tryptophan treatment of aggressive psychiatric patients. Biological Psychiatry (in the press).CrossRefGoogle Scholar\n\nWeissman, M. M., Klerman, G. L.Markowitz, J. S. & Ouellette, R. (1989). Suicidal ideation and suicide attempt in panic disorder and attacks. New England Journal of Medicine 321, 1209–1214.CrossRefGoogle ScholarPubMed"
    }
}